Should patients with cardiovascular disease take fish oil?

CMAJ. Canadian Medical Association Journal

Volumn 178, Issue 2, 2008, Pages 181-182

  Nair, Girish M ^a   Connolly, Stuart J ^a,b  

^a HAMILTON HEALTH SCIENCES   (Canada)

^b HAMILTON GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FISH OIL; OMEGA 3 FATTY ACID;

ANTIARRHYTHMIC ACTIVITY; CARDIOVASCULAR DISEASE; DEFIBRILLATOR; EVALUATION; HEALTH FOOD; HEART DEATH; HEART ELECTROPHYSIOLOGY; HEART INFARCTION; HEART PROTECTION; HEART VENTRICLE ARRHYTHMIA; HUMAN; MORTALITY; NOTE; RISK REDUCTION; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

EID: 38549114013     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.071654     Document Type: Note

References (14)

1. Leaf A, Kang JX, Yong-Fu Xiao YF, et al. Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmia by n-3 fish oils. Circulation 2003;107:2646-52.
2. Hu FB, Bronner L, Willett WC, et al. Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA 2002;287:1815-21.
3. Daviglus ML, Stamler J, Orencia AJ, et al. Fish consumption and the 30-year risk of fatal myocardial infarction. N Engl J Med 1997;336:1046-53.
4. Burr ML, Fehily AM, Gilbert JF, et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 1989;2:757-61.
5. Singh RB, Niaz MA, Sharma JP, et al. Randomized, double-blind, placebo controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian experiment of infarct survival-4. Cardiovasc Drugs Ther 1997;11:485-91.
6. GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999;354:447-55.
7. Schrepf R, Limmert T, Weber PC, et al. Immediate effects of n-3 fatty acid infusion on the induction of sustained ventricular tachycardia. Lancet 2004;363:1441-2.
8. Raitt MH, Connor WE, Morris C, et al. Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial. JAMA 2005;293:2884-91.
9. Leaf A, Albert CM, Josephson M, et al. Prevention of fatal arrhythmia in high risk subjects by fish oil n-3 fatty acid intake. Circulation 2005;112:2762-8.
10. Brouwer IA, Zock PL, Camm AJ, et al. Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators: the Study on Omega-3 Fatty Acids and Ventricular Arrhythmia (SOFA) randomized trial. JAMA 2006;295:2613-9.
11. Jenkins DJA, Josse AR, Beyene J, et al. Fish-oil supplementation in patients with implantable cardioverter defibrillators: a meta-analysis. CMAJ 2008;178:157-64.
12. Hooper L, Thompson RL, Harrison RA, et al. Risks and benefits of omega-3 fats for mortality, cardiovascular disease and cancer: systematic review. BMJ 2006;332: 752-60.
13. Yokoyama M, Origasa H, Matsuzaki M, et al. for the Japan EPA Lipid Intervention Study (JELIS) Investigators. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomized open-label, blinded endpoint analysis. Lancet 2007;369:1090-8.
14. London B, Albert C, Anderson ME, et.al. Omega-3 fatty acids and cardiac arrhythmia: prior studies and recommendations for future research: A report from the National Heart, Lung and Blood Institute and Office of Dietary Supplements Omega-3 Fatty Acids and Their Role in Cardiac Arrhythmogenesis workshop. Circulation 2007;116:e320-e35.